Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (52216)	2/29/2000 9:41:00 PM
From: tcarnes	Respond to of 122087

DEAR A@P THANKS VERY MUCH AGAIN!!!!!!!! VASO HITS 9 IN AFTER TRADING. I KNOW I DON'T POST HERE MUCH BUT I LOOK MOST DAYS. SO FAR YOU HAVE BEEN RIGHT ON EVERY PICK I WENT WITH IMCL, GENE, AVAN, AND A NUMBER OF SHORTS I WON'T COUNT. THANKS AGAIN TJ CARNES.

To: Anthony@Pacific who wrote (52216)	2/29/2000 9:54:00 PM
From: RockyBalboa	Read Replies (1) \| Respond to of 122087

Congrats on VASO, Tony. You and your followers deserved it. After all it was an aftermarket play (though with some liquidity), but who cares! Pecuniam non olet. BR,..

To: Anthony@Pacific who wrote (52216)	2/29/2000 10:53:00 PM
From: McNabb Brothers	Respond to of 122087

Tony, Will you give us an update about your up and coming court case! Not sure I will be able to attend in person! Hank

To: Anthony@Pacific who wrote (52216)	2/29/2000 11:20:00 PM
From: RockyBalboa	Respond to of 122087

Did anyone catch the symbol of that company? Vasomedical (VASO:Nasdaq - news - boards) blindsided Island's most-active chart, careening to the top of the list in just 15 minutes of trading before 5:30 p.m. EST. It shot up 4 1/4 to 7 1/8 on 3.5 million shares. Interest hit a postclose fever pitch after Vasomedical announced additional results of a Mayo Clinic study on its trademark technology, enhanced external counterpulsation therapy, EECP for short. The Mayo Clinic found that 20 of the 21 patients who underwent EECP therapy had shown "positive results" while some cases "improved dramatically." In the press release touting the results, a Mayo Clinic spokesman said he was "cautiously optimistic" about the results. This news from the Mayo Clinic isn't a new thing. It previously released the results of an EECP study in November. In fact, tonight's huge volume and solid gains might have evening denizens feeling deja vu all over again. Vasomedical shot up the charts on Jan. 14, due to positive earnings news and then a week later without any news at all. Tonight's jump covers for a flat, lackluster day session when it inched down 1/32 to 2 29/32. thestreet.com